NJ S3573

Prohibits pharmacy benefits managers (PBMs) from "steering" prescriptions to affiliated or owned pharmacies, including retail, mail-order, and specialty pharmacies, and from requiring covered persons to use mail-order distributors.

Imposes a 10% surcharge on PBMs and health carriers that engage in steering or impose point-of-sale or retroactive fees, calculated on the aggregate dollar amount reimbursed to pharmacies in the previous calendar year.

Requires PBMs to annually attest to the Commissioner of Banking and Insurance whether they engaged in steering and submit prescription drug claims data by March 1, with surcharges due April 1.

Prohibits PBMs from charging copayments exceeding pharmacy reimbursement amounts, sharing patient prescription data with affiliated pharmacies for commercial purposes, charging pharmacy network enrollment fees, or withholding coverage for lower-cost therapeutically equivalent drugs.

Mandates PBMs and carriers publish reports every four months identifying drugs reimbursed 10% above or below the national average drug acquisition cost, including dispensing details and affiliate pharmacy status.